Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma

被引：0
|
作者：
Lu, Xinli [1 ]
Qian, Cheng [2 ]
机构：
[1] Pharmacy Intravenous Admixture Services, The First People's Hospital of Ningyang County, Tai'an, Shandong,271400, China
[2] Department of Thyroid and Breast Surgery, Zhuji People's Hospital of Zhejiang Province, Zhejiang,311800, China
来源：
Computational and Mathematical Methods in Medicine | 2022年 / 2022卷
关键词：
Compendex;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Patient treatment
引用
收藏
相关论文
共 50 条
  • [21] RANDOMIZED CONTROLLED TRIAL OF COMBINED LETROZOLE AND CLOMIPHENE (CLC II) VERSUS LETROZOLE MONOTHERAPY FOR WOMEN WITH ANOVULATION
    Mejia, Rachel B.
    Summers, Karen M.
    Kresowik, Jessica
    Cooney, Laura G.
    Mancuso, Abigail C.
    Capper, Emily A.
    Bhagavath, Bala
    Van Voorhis, Bradley J.
    FERTILITY AND STERILITY, 2024, 122 (04) : E75 - E75
  • [22] Letrozole reduces spread of early breast cancer after tamoxifen therapy in postmenopausal women
    不详
    ONCOLOGY-NEW YORK, 2004, 18 (09): : 1156 - +
  • [23] Extended Therapy With Letrozole and Ovarian Suppression in Premenopausal Patients With Breast Cancer After Tamoxifen
    Ruddy, Kathryn J.
    DeSantis, Stephen D.
    Barry, William
    Guo, Hao
    Block, Caroline C.
    Borges, Virginia
    Winer, Eric P.
    Partridge, Ann H.
    CLINICAL BREAST CANCER, 2014, 14 (06) : 413 - 416
  • [24] Cost-utility analysis of Palbociclib + letrozole and ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival model
    Ali Darvishi
    Rajabali Daroudi
    Ali Akbar Fazaeli
    Health Economics Review, 13
  • [25] Letrozole plus ribociclib versus letrozole plus placebo as neoadjuvant therapy for ER plus breast cancer (FELINE trial).
    Khan, Qamar J.
    O'Dea, Anne
    Bardia, Aditya
    Kalinsky, Kevin
    Wisinski, Kari Braun
    O'Regan, Ruth
    Yuan, Yuan
    Ma, Cynthia X.
    Jahanzeb, Mohammad
    Trivedi, Meghna S.
    Spring, Laura
    Makhoul, Issam
    Wagner, Jamie L.
    Winblad, Onalisa
    Amin, Amanda Leigh
    Blau, Sibel
    Crane, Gregory James
    Elia, Manana
    Hard, Mia
    Sharma, Priyanka
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] Endometrial Surveillance in Tamoxifen and Letrozole Treated Breast Cancer Patients
    AlZaabi, Adhari
    AlAmri, Hafsa
    ALAjmi, Ghadeer
    Allawati, Manhal
    Muhanna, Fatema
    Alabri, Ruqaia
    AlBusaidi, Fatema
    AlGhafri, Shaima
    Al-Mirza, Abdulrahman A.
    Al Baimani, Khalid
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [27] Regression of choroidal metastasis from breast carcinoma following Letrozole therapy
    Venkatesh, Pradeep
    Garg, Satpal
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 35 (05): : 492 - 494
  • [28] Letrozole after tamoxifen for breast cancer - What is the price of success?
    Bryant, J
    Wolmark, N
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (19): : 1855 - 1857
  • [29] Letrozole is superior to tamoxifen for endocrine-responsive breast cancer
    Nature Clinical Practice Oncology, 2008, 5 (4): : 183 - 183
  • [30] A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer
    Thürlimann, B
    Keshaviah, A
    Coates, AS
    Mouridsen, H
    Mauriac, L
    Forbes, JF
    Paridaens, R
    Castiglione-Gertsch, M
    Gelber, RD
    Rabaglio, M
    Smith, I
    Wardly, A
    Price, KN
    Goldhirsch, A
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (26): : 2747 - 2757
12345